BellRock Brands Announces Exclusive Licensing Agreement with Curio Wellness to Produce Mary's Medicinals Wellness Products in Maryland

BellRock anticipates that Mary's products will become available through Curio Wellness during the first quarter of 2022.


DENVER, Oct. 21, 2021 /CNW/ - BellRock Brands Inc., a cannabis multi-state house of brands, today announced that the company has entered into a licensing agreement with Curio Wellness to manufacture and distribute its iconic Mary's Medicinals line to cannabis retailers in Maryland. Curio Wellness, Maryland's market-leading health and wellness company, already manufactures and distributes BellRock's Dixie line of cannabis-infused products. BellRock anticipates that Mary's products, including its Transdermal Patches, Transdermal Gel Pen, Transdermal Compounds and Muscle Freeze, will become available through Curio Wellness during the first quarter of 2022.

Founded in 2013 with the goal of transforming how people view and utilize cannabis, Mary's Medicinals is known for its innovative delivery methods and robust library of intellectual property including a U.S. patent for its acclaimed transdermal technology. In August 2021, BDSA named Mary's Medicinals as the Best-Selling Cannabis Brand in the Topicals Category for 1H 2021.

"We are very pleased to announce an exclusive partnership with Curio Wellness in Maryland," said BellRock President Brian Jansen. "Curio Wellness' history perfectly aligns with the mission and values of Mary's Medicinals. Both companies share an unrelenting commitment to quality, science, and innovation. By unifying Mary's and Dixie under one roof in Maryland, we will benefit from resulting company synergies and expand distribution in the state."

Curio Wellness will manufacture the Mary's Medicinals line in its new, 34,000-square-foot, state-of-the-art processing facility in Timonium, Md. Among the largest in the country, Curio Wellness' facilities are the only in the state whose products meet cGMP standards, the same quality standard set for the world's leading pharmaceutical companies to ensure that consumer products meet the most stringent quality and efficacy guidelines.

"Mary's Medicinals has always been on our radar, lauded for its solid reputation and patient-first mentality. The brand has stood the test of time and has continued to innovate to reimagine wellness for patients," said Michael Bronfein, CEO of Curio Wellness. "We look forward to adding Mary's to the Curio Wellness family and further enhancing and diversifying our offerings to better meet patients' needs."